|
Delayed
NSE India S.E.
03:16:28 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 210.00 INR | -0.40% |
|
-2.33% | +139.04% |
| Market Cap | 2.34B 24.47M 21.32M 20.17M 18.33M 34.24M 34.41M 240M 92.91M 1.19B 91.94M 89.89M 3.81B | P/E 2025 * |
-
| P/E 2026 | 7.04x |
|---|---|---|---|---|---|
| Enterprise Value | 2.43B 25.34M 22.07M 20.89M 18.98M 35.46M 35.63M 249M 96.2M 1.23B 95.19M 93.07M 3.95B | EV / Sales 2025 * |
-
| EV / Sales 2026 | 0.88x |
| Free-Float |
99% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -0.40% | ||
| 1 week | -2.33% | ||
| Current month | +1.45% | ||
| 1 month | +5.00% | ||
| 3 months | +39.07% | ||
| 6 months | +227.87% | ||
| Current year | +139.04% |
| 1 week | 204.05 | 219 | |
| 1 month | 190 | 219 | |
| Current year | 62 | 219 | |
| 1 year | 53.8 | 219 | |
| 3 years | 53.8 | 219 | |
| 5 years | 53.8 | 219 | |
| 10 years | 53.8 | 219 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 38 | 2024-07-08 | |
| Director of Finance/CFO | 40 | 2023-11-28 | |
| Compliance Officer | - | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 39 | 2023-11-28 | |
| Chairman | 40 | 2023-11-28 | |
| Director/Board Member | 38 | 2023-11-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | -2.33% | +234.13% | - | 24.47M | ||
| +1.28% | +2.62% | +51.61% | +100.19% | 1,027B | ||
| +1.10% | +1.45% | +52.49% | +67.37% | 651B | ||
| +0.58% | +3.54% | +19.57% | +73.56% | 467B | ||
| +0.55% | +5.55% | +38.93% | +40.84% | 350B | ||
| +0.40% | +3.96% | +20.46% | +26.58% | 268B | ||
| +0.59% | +6.83% | +11.20% | +16.59% | 257B | ||
| +0.91% | -0.70% | +38.25% | +45.67% | 205B | ||
| +0.32% | +1.41% | -28.57% | -56.90% | 190B | ||
| +2.17% | +4.20% | +34.41% | +99.41% | 187B | ||
| Average | +0.37% | +2.28% | +47.25% | +45.92% | 360.21B | |
| Weighted average by Cap. | -0.03% | +2.62% | +35.31% | +62.18% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 574M 5.99M 5.22M 4.94M 4.49M 8.38M 8.42M 58.82M 22.75M 292M 22.51M 22M 933M | 896M 9.36M 8.15M 7.71M 7.01M 13.09M 13.16M 91.89M 35.53M 455M 35.16M 34.37M 1.46B |
| Net income | 67.94M 709K 618K 585K 531K 993K 997K 6.96M 2.69M 34.53M 2.66M 2.61M 111M | 96.68M 1.01M 879K 832K 756K 1.41M 1.42M 9.91M 3.83M 49.13M 3.79M 3.71M 157M |
| Net Debt | 141M 1.47M 1.28M 1.21M 1.1M 2.05M 2.06M 14.41M 5.57M 71.42M 5.51M 5.39M 229M | 83.01M 867K 755K 714K 649K 1.21M 1.22M 8.51M 3.29M 42.18M 3.26M 3.18M 135M |
Employees
132
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | ₹210.00 | -0.40% | 2,400 |
| 26-09-17 | ₹210.85 | +0.98% | 38,400 |
| 26-09-16 | ₹208.80 | -4.66% | 19,200 |
| 26-09-15 | ₹219.00 | +1.86% | 8,400 |
| 26-09-11 | ₹215.00 | +2.38% | 13,200 |
- Stock Market
- Stocks
- ACCPL Stock
Select your edition
All financial news and data tailored to specific country editions
















